A citation-based method for searching scientific literature

Gary Kohanbash, Diego A Carrera, Shruti Shrivastav, Brian J Ahn, Naznin Jahan, Tali Mazor, Zinal S Chheda, Kira M Downey, Payal B Watchmaker, Casey Beppler, Rolf Warta, Nduka A Amankulor, Christel Herold-Mende, Joseph F Costello, Hideho Okada. J Clin Invest 2017
Times Cited: 158



Anna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, Dorothee Wilhelm, Orsolya Rajky, Sebastian Kurscheid, Philip Kresl, Adelheid Wöhrer, Christine Marosi, Monika E Hegi, Matthias Preusser. Neuro Oncol 2017
Times Cited: 122




List of shared articles



Times cited


Molecular and morphological changes induced by ivosidenib correlate with efficacy in mutant-IDH1 cholangiocarcinoma.
Elia Aguado-Fraile, Ania Tassinari, Yuko Ishii, Carlie Sigel, Maeve A Lowery, Lipika Goyal, Camelia Gliser, Liewen Jiang, Shuchi S Pandya, Bin Wu,[...]. Future Oncol 2021
2

Macrophages and microglia: the cerberus of glioblastoma.
Alice Buonfiglioli, Dolores Hambardzumyan. Acta Neuropathol Commun 2021
2


Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio.
Marike W van Gisbergen, Emma Zwilling, Ludwig J Dubois. Front Oncol 2021
0

The implications of IDH mutations for cancer development and therapy.
Christopher J Pirozzi, Hai Yan. Nat Rev Clin Oncol 2021
1

Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies.
Maria B Garcia-Fabiani, Santiago Haase, Andrea Comba, Stephen Carney, Brandon McClellan, Kaushik Banerjee, Mahmoud S Alghamri, Faisal Syed, Padma Kadiyala, Felipe J Nunez,[...]. Front Oncol 2021
0

Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors.
Runze Qiu, Yue Zhong, Qingquan Li, Yingbin Li, Hongwei Fan. Front Cell Dev Biol 2021
0

IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma.
Xiao Xiang, Ziyang Liu, Chong Zhang, Zhao Li, Jie Gao, Changkun Zhang, Qi Cao, Jinghui Cheng, Hengkang Liu, Dingbao Chen,[...]. Adv Sci (Weinh) 2021
1

Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma.
Lei Lv, Yuliu Zhang, Yujia Zhao, Qinqin Wei, Ye Zhao, Qiyi Yi. Front Cell Neurosci 2021
1

IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?
Alisan Kayabolen, Ebru Yilmaz, Tugba Bagci-Onder. Biomedicines 2021
0

Synthetic lethality and synergetic effect: the effective strategies for therapy of IDH-mutated cancers.
Kun Yao, Hua Liu, Jiajun Yin, Jianmin Yuan, Hong Tao. J Exp Clin Cancer Res 2021
0

An integrated pipeline for comprehensive analysis of immune cells in human brain tumor clinical samples.
Roeltje R Maas, Klara Soukup, Florian Klemm, Mara Kornete, Robert L Bowman, Romain Bedel, Damien N Marie, Ángel F Álvarez-Prado, Danny Labes, Anne Wilson,[...]. Nat Protoc 2021
0

Immunotherapy for Malignant Glioma: Current Status and Future Directions.
Hongxiang Wang, Tao Xu, Qilin Huang, Weilin Jin, Juxiang Chen. Trends Pharmacol Sci 2020
28

Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies.
Ana Rita Pombo Antunes, Isabelle Scheyltjens, Johnny Duerinck, Bart Neyns, Kiavash Movahedi, Jo A Van Ginderachter. Elife 2020
47

Radiomic profiles in diffuse glioma reveal distinct subtypes with prognostic value.
Peng Lin, Yu-Ting Peng, Rui-Zhi Gao, Yan Wei, Xiao-Jiao Li, Su-Ning Huang, Ye-Ying Fang, Zhu-Xin Wei, Zhi-Guang Huang, Hong Yang,[...]. J Cancer Res Clin Oncol 2020
3


Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes.
Ekaterina Friebel, Konstantina Kapolou, Susanne Unger, Nicolás Gonzalo Núñez, Sebastian Utz, Elisabeth Jane Rushing, Luca Regli, Michael Weller, Melanie Greter, Sonia Tugues,[...]. Cell 2020
93

Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target.
Ricardo Gargini, Berta Segura-Collar, Pilar Sánchez-Gómez. Cancers (Basel) 2020
5

New hints towards a precision medicine strategy for IDH wild-type glioblastoma.
K White, K Connor, J Clerkin, B M Murphy, M Salvucci, A C O'Farrell, M Rehm, D O'Brien, J H M Prehn, S P Niclou,[...]. Ann Oncol 2020
7

Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma.
Eliana Marinari, Mathilde Allard, Robin Gustave, Valérie Widmer, Géraldine Philippin, Doron Merkler, Petros Tsantoulis, Valérie Dutoit, Pierre-Yves Dietrich. Oncoimmunology 2020
7

IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice.
Leland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, Xijin S Zheng, Khalifa Stafford, Hiroaki Nagashima, Julie J Miller, Juri Kiyokawa, David T Ting, Hiroaki Wakimoto,[...]. Oncoimmunology 2020
3

Targeting the epigenetic regulation of antitumour immunity.
Simon J Hogg, Paul A Beavis, Mark A Dawson, Ricky W Johnstone. Nat Rev Drug Discov 2020
26


Increased Radiation-Associated T-Cell Infiltration in Recurrent IDH-Mutant Glioma.
Anastasia Makarevic, Carmen Rapp, Steffen Dettling, David Reuss, Christine Jungk, Amir Abdollahi, Andreas von Deimling, Andreas Unterberg, Christel Herold-Mende, Rolf Warta. Int J Mol Sci 2020
0

Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours.
Maximilian J Mair, Sahra Pajenda, Aysegül Ilhan-Mutlu, Ariane Steindl, Barbara Kiesel, Georg Widhalm, Karin Dieckmann, Katharina Feldmann, Johannes Hainfellner, Christine Marosi,[...]. ESMO Open 2020
3

An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors.
Sara Verdura, Elisabet Cuyàs, Jesús Lozano-Sánchez, Cristian Bastidas-Velez, Laura Llorach-Parés, Salvador Fernández-Arroyo, Anna Hernández-Aguilera, Jorge Joven, Alfons Nonell-Canals, Joaquim Bosch-Barrera,[...]. Carcinogenesis 2019
8

Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy.
Pavlina Chuntova, Kira M Downey, Bindu Hegde, Neil D Almeida, Hideho Okada. Front Immunol 2019
27

D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells.
Ines Ugele, Zugey Elizabeth Cárdenas-Conejo, Kathrin Hammon, Monika Wehrstein, Christina Bruss, Katrin Peter, Katrin Singer, Eva Gottfried, Jakob Boesch, Peter Oefner,[...]. Int J Mol Sci 2019
7

Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins.
Bozena Kaminska, Bartosz Czapski, Rafal Guzik, Sylwia Katarzyna Król, Bartlomiej Gielniewski. Molecules 2019
31

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas.
Leland G Richardson, Bryan D Choi, William T Curry. Transl Cancer Res 2019
8